Global Oxcarbazepine (CAS 28721-07-5) Market Outlook 2016-2021

Published: Sep, 2016 | Pages: 98 | Publisher: Gen Consulting Company
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Oxcarbazepine is an anticonvulsant drug primarily used in the treatment of epilepsy. There is some evidence for oxcarbazepine as a mood-stabilizing agent and thus, it can be used as add-on therapy for bipolar disorder in patients that have failed or are unable to tolerate approved treatments.

This report provides detailed analysis of worldwide markets for Oxcarbazepine (CAS 28721-07-5) from 2011-2015 and provides extensive market forecasts 2016-2021 by region/country and subsectors. It covers the key technological and market trends in the Oxcarbazepine (CAS 28721-07-5) market and further lays out an analysis of the factors influencing the supply/demand for Oxcarbazepine (CAS 28721-07-5), and the opportunities/challenges faced by industry participants. It also acts as an essential tool to companies active across the value chain and to the new entrants by enabling them to capitalize the opportunities and develop business strategies.

GCC's report, Global Oxcarbazepine (CAS 28721-07-5) Market Outlook 2016-2021, has been prepared based on the synthesis, analysis, and interpretation of information about the global Oxcarbazepine (CAS 28721-07-5) market collected from specialized sources. The report covers key technological developments in the recent times and profiles leading players in the market and analyzes their key strategies. The competitive landscape section of the report provides a clear insight into the market share analysis of key industry players. The major players in the global Oxcarbazepine (CAS 28721-07-5) market are Novartis (Switzerland), Taj Pharmaceuticals (India), Euticals (Italy), CTX Lifesciences (India), Sun Pharmaceutical (India), Jubilant (India), Zhejiang Jiuzhou (China), Langfang Gaobo (China), Hubei Gedian Humanwell (China), among others.

The report provides separate comprehensive analytics for the North America, Europe, Asia-Pacific, Middle East and Africa and Rest of World. In this sector, global competitive landscape and supply/demand pattern of Oxcarbazepine (CAS 28721-07-5) industry has been provided.

 Table of Contents

Part 1. Scope of Report
1.1 Methodology
1.2 Geographic Scope
1.3 Years Considered

Part 2. Introduction
2.1 Definition
2.2 Current Scenario
2.2 Future Scenario

Part.3 Value Chain Analysis
3.1 Upstream
3.2 Downstream

Part 4. Manufacture
4.1 Manufacturing Process
4.2 Issues and Trends
4.3 Manufacturing Costs

Part 5. Worldwide Key Vendors
5.1 Company A
5.1.1 Business Overview
5.1.2 Products Offered
5.1.3 Business Performance
5.2 Company B
5.3 Company C
5.4 Company D
5.5 Company E
5.6 Company F
5.7 Company G
5.8 Company H
5.9 Company I
5.10 Company J

Part 6. Market Overview
6.1 Global Production Volume 2011-2016
6.2 Production Volume by Region 2011-2016
6.2.1 North America
6.2.2 EMEA
6.2.3 Asia-Pacific
6.2.4 ROW
6.3 Global Production Value 2011-2016
6.4 Production Value by Region
6.4.1 North America
6.4.2 EMEA
6.4.3 Asia-Pacific
6.4.4 ROW

Part 7. Consumption Pattern
7.1 Regional Consumption
7.1.1 North America
7.1.2 EMEA
7.1.3 Asia-Pacific
7.1.4 ROW
7.2 Global Consumption by Application

Part 8. Market Forecast
8.1 Market Size by Volume
8.1.1 North America
8.1.2 EMEA
8.1.3 Asia-Pacific
8.1.4 ROW
8.2 Market Size by Value
8.2.1 North America
8.2.2 EMEA
8.2.3 Asia-Pacific
8.2.4 ROW
8.3 Regional Consumption Forecast
8.3.1 North America
8.3.2 EMEA
8.3.3 Asia-Pacific
8.3.4 ROW
8.4 Consumption Forecast by Application

Part 9. Market Dynamics
9.1 Market Drivers
9.2 Market Constraints
9.3 Market Strategies

Part 10. Key Events
10.1 Mergers & Acquisitions
10.2 New Product Launches
10.3 Expansions
10.4 Other Developments

List of Tables and Figures


Figure Global Oxcarbazepine (CAS 28721-07-5) Production Volume (Unit) 2011-2016
Figure Global Oxcarbazepine (CAS 28721-07-5) Production Value (M USD) 2011-2016
Figure Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production Volume Share 2015
Figure Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production Value Share 2015
Figure Regional Oxcarbazepine (CAS 28721-07-5) Production (Unit) 2015
Figure Regional Oxcarbazepine (CAS 28721-07-5) Production Value (M USD) 2015
Table Raw Material Materials Suppliers
Figure Global Oxcarbazepine (CAS 28721-07-5) Consumption Pattern 2015
Figure Manufacturing Cost Structure
Figure Company A Oxcarbazepine (CAS 28721-07-5) Products
Table Company A Financial Performance 2011-2016
Figure Company A Market Share 2011-2016
Figure Company B Oxcarbazepine (CAS 28721-07-5) Products
Table Company B Financial Performance 2011-2016
Figure Company B Market Share 2011-2016
Figure Company C Oxcarbazepine (CAS 28721-07-5) Products
Table Company C Financial Performance 2011-2016
Figure Company C Market Share 2011-2016
Figure Company D Oxcarbazepine (CAS 28721-07-5) Products
Table Company D Financial Performance 2011-2016
Figure Company D Market Share 2011-2016
Figure Company E Oxcarbazepine (CAS 28721-07-5) Products
Table Company E Financial Performance 2011-2016
Figure Company E Market Share 2011-2016
Figure Company F Oxcarbazepine (CAS 28721-07-5) Products
Table Company F Financial Performance 2011-2016
Figure Company F Market Share 2011-2016
Figure Company G Oxcarbazepine (CAS 28721-07-5) Products
Table Company G Financial Performance 2011-2016
Figure Company G Market Share 2011-2016
Figure Company H Oxcarbazepine (CAS 28721-07-5) Products
Table Company H Financial Performance 2011-2016
Figure Company H Market Share 2011-2016
Figure Company I Oxcarbazepine (CAS 28721-07-5) Products
Table Company I Financial Performance 2011-2016
Figure Company I Market Share 2011-2016
Figure Company J Oxcarbazepine (CAS 28721-07-5) Products
Table Company J Financial Performance 2011-2016
Figure Company J Market Share 2011-2016
Table Global Key Oxcarbazepine (CAS 28721-07-5) Vendors Production (Unit) 2011-2016
Table Global Key Oxcarbazepine (CAS 28721-07-5) Vendors Production Share 2011-2016
Figure Global Oxcarbazepine (CAS 28721-07-5) Capacity & Production (Unit), Capacity Utilization 2011-2016
Figure Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production (Unit) 2011-2016
Table Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production (Unit) 2011
Table Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production (Unit) 2012
Table Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production (Unit) 2013
Table Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production (Unit) 2014
Table Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production (Unit) 2015
Table Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production (Unit) 2016
Figure Oxcarbazepine (CAS 28721-07-5) Production Volume (Unit) 2011-2016
Table Global Production Volume (Unit) 2011-2016
Table Global Production Volume Share 2011-2016
Figure North America Oxcarbazepine (CAS 28721-07-5) Capacity & Production (Unit)
Figure North America Production Share Trend
Figure EMEA Oxcarbazepine (CAS 28721-07-5) Capacity & Production (Unit)
Figure EMEA Production Share Trend
Figure Asia-Pacific Oxcarbazepine (CAS 28721-07-5) Capacity & Production (Unit)
Figure Asia-Pacific Production Share Trend
Figure ROW Oxcarbazepine (CAS 28721-07-5) Capacity & Production (Unit)
Figure ROW Production Share Trend Change
Figure Global Oxcarbazepine (CAS 28721-07-5) Production Value (M USD), Growth Rate
Table Global Key Oxcarbazepine (CAS 28721-07-5) Vendors Production Value (M USD) 2011-2016
Table Global Key Oxcarbazepine (CAS 28721-07-5) Vendors Production Value Share 2011-2016
Figure Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production Value (M USD) 2011-2016
Table Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production Value (M USD) 2011
Table Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production Value (M USD) 2012
Table Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production Value (M USD) 2013
Table Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production Value (M USD) 2014
Table Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production Value (M USD) 2015
Table Global Top 10 Oxcarbazepine (CAS 28721-07-5) Vendors Production Value (M USD) 2016
Figure Oxcarbazepine (CAS 28721-07-5) Prices (USD/Ton) 2016
Figure Oxcarbazepine (CAS 28721-07-5) Gross Margin 2016
Figure Oxcarbazepine (CAS 28721-07-5) Production Value (M USD) By Region 2011-2016
Table Global Oxcarbazepine (CAS 28721-07-5) Production Value (M USD) 2011-2016
Table Global Oxcarbazepine (CAS 28721-07-5) Production Value Share 2011-2016
Figure North America Production Value (M USD), Growth Rate
Figure North America Oxcarbazepine (CAS 28721-07-5) Production Value Share Trend
Figure EMEA Production Value (M USD), Growth Rate
Figure EMEA Oxcarbazepine (CAS 28721-07-5) Production Value Share Trend
Figure Asia-Pacific Production Value (M USD), Growth Rate
Figure Asia-Pacific Oxcarbazepine (CAS 28721-07-5) Production Value Share Trend
Figure ROW Production Value (M USD), Growth Rate
Figure ROW Oxcarbazepine (CAS 28721-07-5) Production Value Share Trend
Figure Global Oxcarbazepine (CAS 28721-07-5) Consumption Volume (Unit) 2015
Table Regional Oxcarbazepine (CAS 28721-07-5) Consumption Volume (Unit) 2011-2016
Table Regional Oxcarbazepine (CAS 28721-07-5) Consumption Volume Share 2011-2016
Figure Oxcarbazepine (CAS 28721-07-5) Consumption in North America 2011-2016
Figure Oxcarbazepine (CAS 28721-07-5) Consumption in EMEA 2011-2016
Figure Oxcarbazepine (CAS 28721-07-5) Consumption in Asia-Pacific 2011-2016
Figure Oxcarbazepine (CAS 28721-07-5) Consumption in ROW 2011-2016
Figure Global Oxcarbazepine (CAS 28721-07-5) Consumption Volume (Unit) 2016
Table Global Oxcarbazepine (CAS 28721-07-5) Consumption Volume (Unit) 2011-2016
Table Global Oxcarbazepine (CAS 28721-07-5) Consumption Volume Share 2011-2016
Figure Global Oxcarbazepine (CAS 28721-07-5) Production (Unit) Forecast 2016-2021
Table Global Oxcarbazepine (CAS 28721-07-5) Production (Unit) 2016-2021
Table Global Oxcarbazepine (CAS 28721-07-5) Production Share 2016-2021
Figure North Oxcarbazepine (CAS 28721-07-5) Production (Unit) Forecast 2016-2021
Figure EMEA Oxcarbazepine (CAS 28721-07-5) Production (Unit) Forecast 2016-2021
Figure Asia-Pacific Oxcarbazepine (CAS 28721-07-5) Production (Unit) Forecast 2016-2021
Figure ROW Oxcarbazepine (CAS 28721-07-5) Production (Unit) Forecast 2016-2021
Figure Global Oxcarbazepine (CAS 28721-07-5) Revenue (M USD) Forecast 2016-2021
Table Global Oxcarbazepine (CAS 28721-07-5) Revenue (M USD) 2016-2021
Table Global Oxcarbazepine (CAS 28721-07-5) Revenue Share 2016-2021
Figure North America Oxcarbazepine (CAS 28721-07-5) Revenue (M USD) Forecast 2016-2021
Figure EMEA Oxcarbazepine (CAS 28721-07-5) Revenue (M USD) Forecast 2016-2021
Figure Asia-Pacific Oxcarbazepine (CAS 28721-07-5) Revenue (M USD) Forecast 2016-2021
Figure ROW Oxcarbazepine (CAS 28721-07-5) Revenue (M USD) Forecast 2016-2021
Figure Global Oxcarbazepine (CAS 28721-07-5) Consumption Volume (Unit) 2016-2021
Table Global Oxcarbazepine (CAS 28721-07-5) Consumption Volume (Unit) 2016-2021
Table Global Oxcarbazepine (CAS 28721-07-5) Consumption Volume Share 2016-2021
Figure North America Oxcarbazepine (CAS 28721-07-5) Consumption (Unit) Forecast
Figure EMEA Oxcarbazepine (CAS 28721-07-5) Consumption (Unit) Forecast
Figure Asia-Pacific Oxcarbazepine (CAS 28721-07-5) Consumption (Unit) Forecast
Figure ROW Oxcarbazepine (CAS 28721-07-5) Consumption (Unit) Forecast
Figure Global Oxcarbazepine (CAS 28721-07-5) Consumption Volume (Unit) 2021
Table Global Oxcarbazepine (CAS 28721-07-5) Consumption Volume (Unit) 2016-2021
Table Global Oxcarbazepine (CAS 28721-07-5) Consumption Volume Share 2016-2021
Table Key Strategies for Oxcarbazepine (CAS 28721-07-5) Multinational Corporations
Table Key Strategies for Oxcarbazepine (CAS 28721-07-5) Emerging-Market Players